FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hervé Fleury

Research Profile

Disorders

Living Beings

Chemicals & Drugs

Concepts & Ideas

Physiology

Procedures

Geographic Areas

France

Co-author Network

Publications

TOP 3
Sandrine Reigadas; Annick Ruffault; Mary-Anne Trabaud; S Yerly; C Amiel; D Descamps; Philippe Flandre; Hervé Fleury; A Houssaïni; A G Marcelin; Bernard Masquelier; J C Plantier
HIV-1 integrase variability and relationship with drug resistance in antiretroviral-naive and -experienced patients with different HIV-1 subtypes.
Hicham El Annaz; Bouchra Belefquih; Toufik Doblali; Saad Mrani; Siham Oumakhir; Patricia Recordon-Pinson; OL Sedrati; Rida Tagajdid; Hervé Fleury
Drug resistance mutations in HIV type 1 isolates from patients failing antiretroviral therapy in Morocco.
A Jaquet; Albert Minga; L Roncin; Annie J Sasco; B Toure; V Charbonneau; P Coffie; François Dabis; Didier K Ekouevi; Hervé Fleury; Isabelle Garrigue; Appolinaire Horo
Cervical human papillomavirus and HIV infection in women of child-bearing age in Abidjan, Côte d'Ivoire, 2010.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hervé Fleury (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sandrine Reigadas; Annick Ruffault; Mary-Anne Trabaud; S Yerly; C Amiel; D Descamps; Philippe Flandre; Hervé Fleury; A Houssaïni; A G Marcelin; Bernard Masquelier; J C Plantier
HIV-1 integrase variability and relationship with drug resistance in antiretroviral-naive and -experienced patients with different HIV-1 subtypes.
The Journal of antimicrobial chemotherapy 2013;68(4):969-72.
2012: Hicham El Annaz; Bouchra Belefquih; Toufik Doblali; Saad Mrani; Siham Oumakhir; Patricia Recordon-Pinson; OL Sedrati; Rida Tagajdid; Hervé Fleury
Drug resistance mutations in HIV type 1 isolates from patients failing antiretroviral therapy in Morocco.
AIDS research and human retroviruses 2012;28(8):944-8.
2012: A Jaquet; Albert Minga; L Roncin; Annie J Sasco; B Toure; V Charbonneau; P Coffie; François Dabis; Didier K Ekouevi; Hervé Fleury; Isabelle Garrigue; Appolinaire Horo
Cervical human papillomavirus and HIV infection in women of child-bearing age in Abidjan, Côte d'Ivoire, 2010.
British journal of cancer 2012;107(3):556-63.
2012: Pascale Trimoulet; Maria Winnock; François Dabis; Hervé Fleury; Marc-Arthur Loko; Laurence Merchadou; Didier Neau; Dominique Salmon
Hepatitis C virus RNA quantitation in a nationwide French cohort of patients co-infected with HIV and HCV: should the same test be applied to all samples?
Journal of virological methods 2012;181(1):131-3.
2012: Patricia Recordon-Pinson; Sandrine Reigadas; Alaka Deshpande; Jennifer Papuchon; Hervé Fleury
K65R in subtype C HIV-1 isolates from patients failing on a first-line regimen including d4T or AZT: comparison of Sanger and UDP sequencing data.
PloS one 2012;7(5):e36549.
2012: Erika Castro; Matthias Cavassini; Patricia Recordon-Pinson; Hervé Fleury
Multiclass primary antiretroviral drug resistance in a patient presenting HIV-1/2 dual infection.
Antiviral therapy 2012;17(3):593-4.
2011: Pascale Trimoulet; L Wittkop; J-M Ragnaud; Sandrine Reigadas; C Belzunce; Michel Dupon; M Faure; Hervé Fleury; Didier Neau
Hepatitis C virus (HCV) protease variability and anti-HCV protease inhibitor resistance in HIV/HCV-coinfected patients.
HIV medicine 2011;12(8):506-9.
2011: Hicham El Annaz; Nabil Baba; Saad Mrani; Patricia Recordon-Pinson; Omar Sedrati; Hervé Fleury
Presence of drug resistance mutations among drug-naive patients in Morocco.
AIDS research and human retroviruses 2011;27(8):917-20.
2011: S Reigadas; M Vandenhende; C Calmels; Hervé Fleury; M Laguerre; Estibaliz Lazaro; Bernard Masquelier; Didier Neau; M L Andréola
Structure-analysis of the HIV-1 integrase Y143C/R raltegravir resistance mutation in association with the secondary mutation T97A.
Antimicrobial agents and chemotherapy 2011;55(7):3187-94.
2011: Mathias Bruyand; Marie-Anne Vandenhende; Guillaume Marcel; Estibaliz Lazaro; Marie-Edith Lafon; Michel Dupon; François Dabis; Stéphane Geffard; Hervé Fleury; Muriel Faure-Della Corte; Fabrice Bonnet; Rodolphe Thiebaut; Isabelle Garrigue
CMV plasma DNAemia and risk of cancer among HIV-infected patients: a case-control study nested in the ANRS CO3 Aquitaine Cohort, France, 2002-2007.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2011;50(2):177-80.
2010: Daniel da Silva; Liesbeth Van Wesenbeeck; Dominique Breilh; Sandrine Reigadas; Guerric Anies; Kurt Van Baelen; Philippe Morlat; Didier Neau; Michel Dupon; Linda Wittkop; Hervé Fleury; Bernard Masquelier
HIV-1 resistance patterns to integrase inhibitors in antiretroviral-experienced patients with virological failure on raltegravir-containing regimens.
The Journal of antimicrobial chemotherapy 2010;65(6):1262-9.
2010: Sandrine Reigadas; Marie-Line Andréola; Linda Wittkop; Ophélie Cosnefroy; Guerric Anies; Patricia Recordon-Pinson; Rodolphe Thiébaut; Bernard Masquelier; Hervé Fleury
Evolution of 2-long terminal repeat (2-LTR) episomal HIV-1 DNA in raltegravir-treated patients and in in vitro infected cells.
The Journal of antimicrobial chemotherapy 2010;65(3):434-7.
2009: Dominique Breilh; Sarah Djabarouti; Pascale Trimoulet; Brigitte Le Bail; Michel Dupon; Jean-Marie Ragnaud; Hervé Fleury; Marie-Claude Saux; Rodolphe Thiébaut; Geneviève Chêne; Didier Neau
Ribavirin plasma concentration predicts sustained virological response to peginterferon Alfa 2a plus ribavirin in previously treated HCV-HIV-coinfected patients.
Journal of acquired immune deficiency syndromes (1999) 2009;52(3):428-30.
2009: Thierry Pistone; Khaled Ezzedine; Marie Boisvert; Marie-Catherine Receveur; Isabelle Schuffenecker; Hervé Zeller; Marie-Edith Lafon; Hervé Fleury; Denis Malvy
Cluster of chikungunya virus infection in travelers returning from Senegal, 2006.
Journal of travel medicine 2009;16(4):286-8.
2009: Patricia Recordon-Pinson; Guerric Anies; Mathias Bruyand; Didier Neau; Philippe Morlat; Jean-Luc Pellegrin; Alexis Groppi; Rodolphe Thiébaut; François Dabis; Hervé Fleury; Bernard Masquelier
HIV type-1 transmission dynamics in recent seroconverters: relationship with transmission of drug resistance and viral diversity.
Antiviral therapy 2009;14(4):551-6.
2008: Isabelle Garrigue; Muriel Faure-Della Corte; Noel MAGNIN; Patricia Recordon-Pinson; Lionel Couzi; Marie-Elise Lebrette; Marie-Hélène Schrive; Loïc Roncin; Jean-Luc Taupin; Julie Déchanet-Merville; Hervé Fleury; Marie-Edith Lafon
UL40 human cytomegalovirus variability evolution patterns over time in renal transplant recipients.
Transplantation 2008;86(6):826-35.
2008: Olivia Peuchant; Rodolphe Thiébaut; Sophie Capdepont; Valérie Lavignolle-Aurillac; Didier Neau; Philippe Morlat; François Dabis; Hervé Fleury; Bernard Masquelier
Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy.
AIDS (London, England) 2008;22(12):1417-23.
2008: Isabelle Garrigue; Adélaïde Doussau; Julien Asselineau; Hélène Bricout; Lionel Couzi; Catherine Rio; Pierre Merville; Hervé Fleury; Marie-Edith Lafon; Rodolphe Thiébaut
Prediction of cytomegalovirus (CMV) plasma load from evaluation of CMV whole-blood load in samples from renal transplant recipients.
Journal of clinical microbiology 2008;46(2):493-8.
2008: Isabelle Pellegrin; Linda Wittkop; Laurence Morand Joubert; Didier Neau; Diane Bollens; Mojgan Bonarek; Pierre-Marie Girard; Hervé Fleury; Bart Winters; Marie-Claude Saux; Jean-Luc Pellegrin; Rodolphe Thiébaut; Dominique Breilh
Virological response to darunavir/ritonavir-based regimens in antiretroviral-experienced patients (PREDIZISTA study).
Antiviral therapy 2008;13(2):271-9.
2008: Cyril Masante; Kathleen Mahias; Sofia Lourenço; Estelle Dumas; Annie Cahour; Pascale Trimoulet; Hervé Fleury; Thérèse Astier-Gin; Michel Ventura
Seven nucleotide changes characteristic of the hepatitis C virus genotype 3 5' untranslated region: correlation with reduced in vitro replication.
The Journal of general virology 2008;89(Pt 1):212-21.
2007: Pascale Trimoulet; Mathieu Boutonnet; Maria Winnock; Muriel Faure; Marc-Arthur Loko; Victor de Lédinghen; Pierre-Henri Bernard; Laurent Castéra; Juliette Foucher; Michel Dupon; Jean-Marie Ragnaud; Marie-Edith Lafon; Patrice Couzigou; François Dabis; Hervé Fleury; Didier Neau
Hepatitis B virus genotypes: a retrospective survey in Southwestern France, 1999-2004.
Gastroentérologie clinique et biologique 2007;31(12):1088-94.
2007: Isabelle Garrigue; Muriel Faure-Della Corte; Noel MAGNIN; Lionel Couzi; Sophie Capdepont; Catherine Rio; Pierre Merville; Julie Dechanet-Merville; Hervé Fleury; Marie-Edith Lafon
Variability of UL18, UL40, UL111a and US3 immunomodulatory genes among human cytomegalovirus clinical isolates from renal transplant recipients.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2007;40(2):120-8.
2007: Bruno Herpe; Isabelle Schuffenecker; Jérome Pillot; Denis Malvy; Benjamin Clouzeau; Nam Bui; Frederic Vargas; Didier Gruson; Hervé Zeller; Marie E Lafon; Hervé Fleury; Gilles Hilbert
Tickborne encephalitis, southwestern France.
Emerging infectious diseases 2007;13(7):1114-6.
2007: Isabelle Pellegrin; Dominique Breilh; Gaelle Coureau; Sébastien Boucher; Didier Neau; Patrick Merel; Denis Lacoste; Hervé Fleury; Marie-Claude Saux; Jean-Luc Pellegrin; Estibaliz Lazaro; François Dabis; Rodolphe Thiébaut
Interpretation of genotype and pharmacokinetics for resistance to fosamprenavir-ritonavir-based regimens in antiretroviral-experienced patients.
Antimicrobial agents and chemotherapy 2007;51(4):1473-80.
2007: Jean-François Viallard; Estibaliz Lazaro; Emmanuel Ellie; S Eimer; Fabrice Camou; Olivier Caubet; Marie-Edith Lafon; Hervé Fleury; Jean-Luc Pellegrin
Improvement of progressive multifocal leukoencephalopathy after cidofovir therapy in a patient with a destructive polyarthritis.
Infection 2007;35(1):33-6.
2007: Olivia Peuchant; Sophie Capdepont; Jean-Marie Ragnaud; Valérie Aurillac-Lavignolle; Rodolphe Thiébaut; Hervé Fleury; Bernard Masquelier
Primary resistance to enfuvirtide (T20) in recently HIV-1 infected, antiretroviral-naive patients from the ANRS Aquitaine Cohort.
Antiviral therapy 2007;12(4):559-62.
2007: Victor de Lédinghen; Pascale Trimoulet; Paul-Régis Mannant; Francis Dumas; Patrick Champbenoît; Christian Baldit; Juliette Foucher; Muriel Faure; Julien Vergniol; Laurent Castéra; Julien Bertet; Hervé Fleury; Patrice Couzigou; Pierre-Henri Bernard
Outbreak of hepatitis C virus infection during sclerotherapy of varicose veins: long-term follow-up of 196 patients (4535 patient-years).
Journal of hepatology 2007;46(1):19-25.
2006: Sarah Djabarouti; Dominique Breilh; Isabelle Pellegrin; Michel Lavit; Fabrice Camou; Olivier Caubet; Hervé Fleury; Marie-Claude Saux; Jean-Luc Pellegrin
Intracellular and plasma efavirenz concentrations in HIV-infected patients switching from successful protease inhibitor-based highly active antiretroviral therapy (HAART) to efavirenz-based HAART (SUSTIPHAR Study).
The Journal of antimicrobial chemotherapy 2006;58(5):1090-3.
2006: Fabrice Bonnet; Anne-Christine Jouvencel; Marie Parrens; Magali Joblon Leon; Emmanuelle Cotto; Isabelle Garrigue; Philippe Morlat; Jacques Beylot; Hervé Fleury; Marie-Edith Lafon
A longitudinal and prospective study of Epstein-Barr virus load in AIDS-related non-Hodgkin lymphoma.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2006;36(4):258-63.
2006: Sébastien Boucher; Patricia Recordon-Pinson; Jean-Marie Ragnaud; Michel Dupon; Hervé Fleury; Bernard Masquelier
HIV-1 reverse transcriptase (RT) genotypic patterns and treatment characteristics associated with the K65R RT mutation.
HIV medicine 2006;7(5):294-8.
2006: Eric Balestre; Michel Dupon; Sophie Capdepont; Rodolphe Thiébaut; Sébastien Boucher; Hervé Fleury; François Dabis; Bernard Masquelier
Virological response to HIV-1 nucleoside/nucleotide reverse transcriptase inhibitors-based, tenofovir DF-including regimens in the ANRS Aquitaine Cohort.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2006;36(2):95-9.
2006: Anne-Christine Jouvencel; Didier Neau; Muriel Faure; Martine Neau; Christophe Martinaud; Elisabeth Legrand; Pascale Trimoulet; Isabelle Garrigue; Brigitte Le Bail; Paulette Bioulac-Sage; Michel Dupon; Jean-Marie Ragnaud; Hervé Fleury; Marie-Edith Lafon
Plasma and liver hepatitis C virus variability in patients coinfected with human immunodeficiency virus.
Journal of clinical microbiology 2006;44(5):1877-80.
2006: Sophie Capdepont; Valérie Aurillac-Lavignolle; Muriel Faure; Michel Dupon; Philippe Morlat; Jean-Marie Ragnaud; Geneviève Chêne; Hervé Fleury; Bernard Masquelier
An additive/subtractive genotypic score as a determinant of the virological response to didanosine in HIV-1 infected patients.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2006;36(1):36-42.
2006: Isabelle Garrigue; Sébastien Boucher; Lionel Couzi; Anne Caumont; Claire Dromer; Martine Neau-Cransac; Reza Tabrizi; Marie-Hélène Schrive; Hervé Fleury; Marie-Edith Lafon
Whole blood real-time quantitative PCR for cytomegalovirus infection follow-up in transplant recipients.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2006;36(1):72-5.
2006: Yves Benhamou; Hervé Fleury; Pascale Trimoulet; Isabelle Pellegrin; Renaud Urbinelli; Christine Katlama; Willy Rozenbaum; Gwenael Le Teuff; Aldo Trylesinski; Christophe Piketty
Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients.
Hepatology (Baltimore, Md.) 2006;43(3):548-55.
2006: Bernard Masquelier; Didier Neau; Sébastien Boucher; Valérie Lavignolle-Aurillac; Marie-Hélène Schrive; Patricia Recordon-Pinson; Jean-Marie Ragnaud; Hervé Fleury
Antiretroviral efficacy and virological profile of a zidovudine/lamivudine/tenofovir disoproxil fumarate combination therapy in antiretroviral-naive patients.
Antiviral therapy 2006;11(6):827-30.
2006: Isabelle Pellegrin; Dominique Breilh; Jean-Marie Ragnaud; Sébastien Boucher; Didier Neau; Hervé Fleury; Marie-Hélène Schrive; Marie-Claude Saux; Jean-Luc Pellegrin; Estibaliz Lazaro; Muriel Vray
Virological responses to atazanavir-ritonavir-based regimens: resistance-substitutions score and pharmacokinetic parameters (Reyaphar study).
Antiviral therapy 2006;11(4):421-9.
2006: Daniela Bezemer; Anthony de Ronde; Maria Prins; Kholoud Porter; Robert James Gifford; Deenan Pillay; Bernard Masquelier; Hervé Fleury; François Dabis; Nicole Back; Suzanne Jurriaans; Lia van der Hoek
Evolution of transmitted HIV-1 with drug-resistance mutations in the absence of therapy: effects on CD4+ T-cell count and HIV-1 RNA load.
Antiviral therapy 2006;11(2):173-8.
2005: Bernard Masquelier; Krishnan Bhaskaran; Deenan Pillay; Robert James Gifford; Eric Balestre; Louise B Jørgensen; Court Pedersen; Lia van der Hoek; Maria Prins; Claudia Balotta; Benedetta Longo; Claudia Kücherer; Gabriele Poggensee; Marta Ortiz; Carmen de Mendoza; John Gill; Hervé Fleury; Kholoud Porter
Prevalence of transmitted HIV-1 drug resistance and the role of resistance algorithms: data from seroconverters in the CASCADE collaboration from 1987 to 2003.
Journal of acquired immune deficiency syndromes (1999) 2005;40(5):505-11.
2005: Sébastien Boucher; Patricia Recordon-Pinson; Didier Neau; Jean-Marie Ragnaud; Karine Titier; Muriel Faure; Hervé Fleury; Bernard Masquelier
Clonal analysis of HIV-1 variants in proviral DNA during treatment interruption in patients with multiple therapy failures.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2005;34(4):288-94.
2005: Isabelle Pellegrin; Rodolphe Thiébaut; Patrick Blanco; Jean-François Viallard; Marie-Hélène Schrive; Patrick Merel; Geneviève Chêne; Hervé Fleury; Jean-François Moreau; Jean-Luc Pellegrin
Can highly active antiretroviral therapy be interrupted in patients with sustained moderate HIV RNA and > 400 CD4+ cells/microl? Impact on immunovirological parameters.
Journal of medical virology 2005;77(2):164-72.
2005: André Inwoley; Patricia Recordon-Pinson; Marion Dupuis; Jessintha Gaston; Mathieu Genête; Albert Minga; Franck Letourneur; François Rouet; Jeannine Choppin; Hervé Fleury; Jean-Gérard Guillet; Muriel Andrieu
Cross-clade conservation of HIV type 1 Nef immunodominant regions recognized by CD8+ T cells of HIV type 1 CRF02_AG-infected Ivorian (West Africa).
AIDS research and human retroviruses 2005;21(7):620-8.
2005: Estibaliz Lazaro; Ioannis Theodorou; Elisabeth Legrand; Patricia Recordon-Pinson; Sébastien Boucher; Corinne Capoulade; Thi Hoang Lan; Pham Van Hung; Patrice Debre; Hervé Fleury
Sequences of clustered epitopes in Gag and Nef potentially presented by predominant class I human leukocyte antigen (HLA) alleles A and B expressed by human immunodeficiency virus type 1 (HIV-1)-infected patients in Vietnam.
AIDS research and human retroviruses 2005;21(6):586-91.
2005: Victor de Lédinghen; Pascale Trimoulet; Géraldine Cazajous; Pierre-Henri Bernard; Marie-Hélène Schrive; Juliette Foucher; Muriel Faure; Laurent Castéra; Julien Vergniol; Michel Amouretti; Hervé Fleury; Patrice Couzigou
Epidemiological and phylogenetic evidence for patient-to-patient hepatitis C virus transmission during sclerotherapy of varicose veins.
Journal of medical virology 2005;76(2):279-84.
2005: Didier Neau; Maria Winnock; Anne-Christine Jouvencel; Murielle Faure; Laurent Castéra; Elisabeth Legrand; Denis Lacoste; Jean-Marie Ragnaud; Michel Dupon; Hervé Fleury; Marie-Edith Lafon; François Dabis
Occult hepatitis B virus infection in HIV-infected patients with isolated antibodies to hepatitis B core antigen: Aquitaine cohort, 2002-2003.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;40(5):750-3.
2005: Rodolphe Thiébaut; Isabelle Pellegrin; Geneviève Chêne; Jean-François Viallard; Hervé Fleury; Jean-François Moreau; Jean-Luc Pellegrin; Patrick Blanco
Immunological markers after long-term treatment interruption in chronically HIV-1 infected patients with CD4 cell count above 400 x 10(6) cells/l.
AIDS (London, England) 2005;19(1):53-61.
2004: Lionel Couzi; Delphine Morel; Pierre Merville; Pascale Trimoulet; Hervé Fleury
Acute hepatitis associated with hepatitis G virus primo-infection in a renal transplant recipient.
Transplantation 2004;78(6):951-3.
2004: Pascale Trimoulet; Victor de Lédinghen; Juliette Foucher; Laurent Castéra; Hervé Fleury; Patrice Couzigou
Predictive value of early HCV RNA quantitation for sustained response in nonresponders receiving daily interferon and ribavirin therapy.
Journal of medical virology 2004;72(1):46-51.
2003: Emmanuelle Cotto; Didier Neau; Martine Cransac-Neau; Marc Auriacombe; Jean-Luc Pellegrin; Jean-Marie Ragnaud; Anne-Marie Fillet; Magali Belnard; Hervé Fleury; Marie-Edith Lafon
Borna disease virus RNA in immunocompromised patients in southwestern France.
Journal of clinical microbiology 2003;41(12):5577-81.
2003: Didier Neau; Anne-Christine Jouvencel; Elisabeth Legrand; Pascale Trimoulet; Tatiana Galperine; Isabelle Chitty; Michel Ventura; Brigitte Le Bail; Philippe Morlat; Jean-Yves Lacut; Jean-Marie Ragnaud; Michel Dupon; Hervé Fleury; Marie-Edith Lafon
Hepatitis C virus genetic variability in 52 human immunodeficiency virus-coinfected patients.
Journal of medical virology 2003;71(1):41-8.
2003: Didier Neau; Tatiana Galpérine; Elisabeth Legrand; Vincent Pitard; Martine Neau-Cransac; Jean-François Moreau; Jean-Marie Ragnaud; Michel Dupon; Hervé Fleury; Marie-Edith Lafon
T-lymphocyte populations in hepatitis C and HIV co-infected patients treated with interferon-alfa-2a and ribavirin.
HIV medicine 2003;4(2):120-6.
2003: Hervé Fleury; Patricia Recordon-Pinson; Anne Caumont; Muriel Faure; Pierre Roques; Jean-Christophe Plantier; Elisabeth Couturier; Dominique Dormont; Bernard Masquelier; François Simon
HIV type 1 diversity in France, 1999-2001: molecular characterization of non-B HIV type 1 subtypes and potential impact on susceptibility to antiretroviral drugs.
AIDS research and human retroviruses 2003;19(1):41-7.
2003: Isabelle Pellegrin; Anne Caumont; Isabelle Garrigue; Patrick Merel; Marie-Hélène Schrive; Hervé Fleury; Michel Dupon; Jean-Luc Pellegrin; Jean-Marie Ragnaud
Predictive value of provirus load and DNA human immunodeficiency virus genotype for successful abacavir-based simplified therapy.
The Journal of infectious diseases 2003;187(1):38-46.
2002: Bernard Masquelier; Dominique Breilh; Didier Neau; Sylvie Lawson-Ayayi; Valérie Lavignolle; Jean-Marie Ragnaud; Michel Dupon; Philippe Morlat; François Dabis; Hervé Fleury
Human immunodeficiency virus type 1 genotypic and pharmacokinetic determinants of the virological response to lopinavir-ritonavir-containing therapy in protease inhibitor-experienced patients.
Antimicrobial agents and chemotherapy 2002;46(9):2926-32.
2002: Elisabeth Legrand; Didier Neau; Tatiana Galperine; Pascale Trimoulet; Jean-François Moreau; Vincent Pitard; Jean-Yves Lacut; Jean-Marie Ragnaud; Michel Dupon; Brigitte Le Bail; Noëlle Bernard; Evelyne Schvoerer; Michael Houghton; Hervé Fleury; Marie-Edith Lafon
CD4 T lymphocyte proliferative responses to hepatitis C virus (HCV) antigens in patients coinfected with HCV and human immunodeficiency virus who responded to anti-HCV treatment.
The Journal of infectious diseases 2002;186(3):302-11.
2002: Victor de Lédinghen; Pascale Trimoulet; Maria Winnock; Pierre-Henri Bernard; Marc Bourlière; Isabelle Portal; André-Jean Rémy; Nathalie Szostak; Stéphane Lévy; Albert Tran; Armand Abergel; Geneviève Chêne; Hervé Fleury; Patrice Couzigou
Daily or three times per week interferon alpha-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C not responding to previous interferon alone.
Journal of hepatology 2002;36(6):819-26.
2002: Pascale Trimoulet; Philippe Halfon; Eric Pohier; Hacène Khiri; Geneviève Chêne; Hervé Fleury
Evaluation of the VERSANT HCV RNA 3.0 assay for quantification of hepatitis C virus RNA in serum.
Journal of clinical microbiology 2002;40(6):2031-6.
2002: Pascale Trimoulet; Didier Neau; Brigitte Le Bail; Anne Rullier; Maria Winnock; Tatiana Galperine; Elisabeth Legrand; Evelyne Schvoerer; Michel Dupon; Jean-Marie Ragnaud; Paulette Bioulac-Sage; Geneviève Chêne; Hervé Fleury; Marie-Edith Lafon
Intrahepatic HCV RNA loads in 37 HIV-HCV co-infected patients with controlled HIV infection.
Journal of medical virology 2002;67(2):143-51.
2002: Victor de Lédinghen; Pascale Trimoulet; Maria Winnock; Juliette Foucher; Marc Bourlière; Hervé Desmorat; Valérie Canva; Dominique Capron; Stéphane Lévy; François Mion; Paul-Régis Mannant; Geneviève Chêne; Hervé Fleury; Patrice Couzigou; Pierre-Henri Bernard
Daily or three times a week interferon alfa-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C.
Journal of hepatology 2002;36(5):672-80.
2002: Thomas d'Aquin Toni; Bernard Masquelier; Dominique Bonard; Muriel Faure; Charlotte Huët; Anne Caumont; Pierre Roques; François Dabis; Roger Salamon; Hervé Fleury
Primary HIV-1 drug resistance in Abidjan (Côte d'Ivoire): a genotypic and phenotypic study.
AIDS (London, England) 2002;16(3):488-91.
2002: Evelyne Schvoerer; Imed Kabissa; Emmanuelle Cotto; Anne-Christine Jouvencel; Charles Balabaud; Victor de Ledinghen; Patrice Couzigou; André Quinton; Claire Schvoerer; Marie-Edith Lafon; Hervé Fleury; Pierre-Henri Bernard
Lamivudine therapy of chronic hepatitis B in three groups of patients: non transplanted patients, liver recipients, and kidney recipients.
Gastroentérologie clinique et biologique 2002;26(1):62-6.
2001: Patrick Merel; Isabelle Pellegrin; Isabelle Garrigue; Anne Caumont; Marie-Hélène Schrive; V Birac; P Bonot; Hervé Fleury
Comparison of capillary electrophoresis sequencing with the new CEQ 2000 DNA Analysis System to conventional gel based systems for HIV drug resistance analysis.
Journal of virological methods 2001;98(1):9-16.
2001: Didier Neau; Pascale Trimoulet; Maria Winnock; Brigitte Le Bail; Evelyne Schvoerer; Elisabeth Legrand; Jean-Marie Ragnaud; Michel Dupon; Hervé Fleury; Marie-Edith Lafon
Impact of protease inhibitors on intrahepatic hepatitis C virus viral load.
AIDS (London, England) 2001;15(13):1736-8.
2001: Isabelle Pellegrin; Isabelle Garrigue; Anne Caumont; Jean-Luc Pellegrin; Patrick Merel; Marie-Hélène Schrive; P Bonot; Hervé Fleury
Persistence of zidovudine-resistance mutations in HIV-1 isolates from patients removed from zidovudine therapy for at least 3 years and switched to a stavudine-containing regimen.
AIDS (London, England) 2001;15(8):1071-3.
2000: Isabelle Garrigue; Isabelle Pellegrin; Bruno Hoen; B Dumon; Martine Harzic; Marie-Hélène Schrive; D Séréni; Hervé Fleury
Cell-associated HIV-1-DNA quantitation after highly active antiretroviral therapy-treated primary infection in patients with persistently undetectable plasma HIV-1 RNA.
AIDS (London, England) 2000;14(18):2851-5.
2000: Isabelle Pellegrin; MICHEL SEGONDY; Isabelle Garrigue; Jacques Izopet; Brigitte Montes; Jean-Luc Pellegrin; Jacques Reynes; P Massip; J Puel; Hervé Fleury
Phenotypic resistance pattern of HIV-1 isolates with zidovudine and/or multidrug resistance mutations after didanosine-stavudine combination therapy.
Journal of acquired immune deficiency syndromes (1999) 2000;25(5):465-6.
2000: Pascale Trimoulet; Victor de Lédinghen; Didier K Ekouevi; Pierre-Henri Bernard; Patrick Merel; Geneviève Chêne; Patrice Couzigou; Hervé Fleury
TT virus infection during chronic hepatitis C.
The American journal of gastroenterology 2000;95(7):1765-9.
2000: Isabelle Pellegrin; Isabelle Garrigue; Didier K Ekouevi; Lionel Couzi; Pierre Merville; Patrick Merel; Geneviève Chene; Marie-Hélène Schrive; Pascale Trimoulet; Marie-Edith Lafon; Hervé Fleury
New molecular assays to predict occurrence of cytomegalovirus disease in renal transplant recipients.
The Journal of infectious diseases 2000;182(1):36-42.
2000: Elisabeth Couturier; Florence Damond; Pierre Roques; Hervé Fleury; Francis Barin; JB Brunet; F Brun-Vézinet; F Simon
HIV-1 diversity in France, 1996-1998. The AC 11 laboratory network.
AIDS (London, England) 2000;14(3):289-96.
2000: Pascale Trimoulet; Pierre-Henri Bernard; Victor de Ledinghen; B Oui; Geneviève Chene; MF Saint-Marc-Girardin; S Dantin; Patrice Couzigou; Hervé Fleury
Quantitation of hepatitis C virus RNA in plasma and peripheral blood mononuclear cells of patients with chronic hepatitis treated with interferon-alpha.
Digestive diseases and sciences 2000;45(1):175-81.
1999: Isabelle Pellegrin; Isabelle Garrigue; Christine Binquet; Geneviève Chene; Didier Neau; P Bonot; Fabrice Bonnet; Hervé Fleury; Jean-Luc Pellegrin
Evaluation of new quantitative assays for diagnosis and monitoring of cytomegalovirus disease in human immunodeficiency virus-positive patients.
Journal of clinical microbiology 1999;37(10):3124-32.
1999: Bruno Hoen; B Dumon; Martine Harzic; Alain Venet; Béatrice Dubeaux; C Lascoux; Y Bourezane; Jean-Marie Ragnaud; A Bicart-See; François Raffi; L Beauvais; Hervé Fleury; D Séréni
Highly active antiretroviral treatment initiated early in the course of symptomatic primary HIV-1 infection: results of the ANRS 053 trial.
The Journal of infectious diseases 1999;180(4):1342-6.
1999: Isabelle Pellegrin; Jacques Izopet; Jacques Reynes; M Denayrolles; Brigitte Montes; Jean-Luc Pellegrin; P Massip; J Puel; Hervé Fleury; MICHEL SEGONDY
Emergence of zidovudine and multidrug-resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus didanosine combination therapy. STADI Group.
AIDS (London, England) 1999;13(13):1705-9.
1999: Patrick Mercié; I Devianne; Jean-François Viallard; I Faure; Isabelle Pellegrin; Bingfeng Leng; Michel Dupon; P Barbeau; Hervé Fleury; Jean-Luc Pellegrin
Vascular endothelial growth factor (VEGF165) plasma level increase with immunodepression in AIDS patients with Kaposi's sarcoma.
Microvascular research 1999;57(2):208-10.
1998: Joël Constans; Viviane Guérin; A Couchouron; Martine Seigneur; A Ryman; Andrew D Blann; J Amiral; A Amara; Evelyne Peuchant; J F Moreau; Isabelle Pellegrin; J L Pellegrin; Hervé Fleury; Bingfeng Leng; Claude Conri
Autoantibodies directed against phospholipids or human beta 2-glycoprotein I in HIV-seropositive patients: relationship with endothelial activation and antimalonic dialdehyde antibodies.
European journal of clinical investigation 1998;28(2):115-22.
1997: R El Dirani-Diab; L Sarih-Cottin; B Delord; B Dumon; S Moreau; J J Toulme; Hervé Fleury; Simon Litvak
Phosphorothioate oligonucleotides derived from human immunodeficiency virus type 1 (HIV-1) primer tRNALys3 are strong inhibitors of HIV-1 reverse transcriptase and arrest viral replication in infected cells.
Antimicrobial agents and chemotherapy 1997;41(10):2141-8.